EFFECTS OF IRBESARTAN ON SERUM LEVEL OF LEPTIN IN PATIENTS WITH ACUTE CEREBRAL INFARCTION
Chen We
Abstract
Chen We
Abstract
[Objective] To observe the effects of irbesartan on serum level of leptin in patients with acute cerebral infarction(ACI).[Methods]89 subjects were divided into control group(n = 27),ACI control group(n = 32)and ACI treatment group(n = 30).Patients in both ACI groups were given conventional medicine treatment for 2 weeks,and patients in the ACI treatment group oral irbesartan(150mg/day)for 2 weeks.Blood pressure(Bp),blood lipid,the level of high sensitivity C-reactive protein(hs-CRP)and leptin were measured and the scores of neurological deficit(NDS)were evaluated before and after treatment in all subjects.[Results]Compared to those in the control group,the Bp,TG,Th,LDL and hs-CRP as well as leptin were obviously increased in both ACI groups(P﹤0.01).The hs-CRP and leptin were obviously decreased in both ACI groups after treatment for 2 weeks(P﹤0.05),the changes were significant in the ACI treatment group compare to those in the ACI control group(P﹤0.05).NDS were improved after treatment in both ACI groups.However,lowering of NDS after treatment in the ACI treatment group were more apparent compare to those in the ACI control group(P﹤0.05).[Conclusion]Irbesartan can decrease serum level of leptin,and improve the recovery of neurological function in patients with ACI.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
[Objective] To observe the effects of irbesartan on serum level of leptin in patients with acute cerebral infarction(ACI).[Methods]89 subjects were divided into control group(n = 27),ACI control group(n = 32)and ACI treatment group(n = 30).Patients in both ACI groups were given conventional medicine treatment for 2 weeks,and patients in the ACI treatment group oral irbesartan(150mg/day)for 2 weeks.Blood pressure(Bp),blood lipid,the level of high sensitivity C-reactive protein(hs-CRP)and leptin were measured and the scores of neurological deficit(NDS)were evaluated before and after treatment in all subjects.[Results]Compared to those in the control group,the Bp,TG,Th,LDL and hs-CRP as well as leptin were obviously increased in both ACI groups(P﹤0.01).The hs-CRP and leptin were obviously decreased in both ACI groups after treatment for 2 weeks(P﹤0.05),the changes were significant in the ACI treatment group compare to those in the ACI control group(P﹤0.05).NDS were improved after treatment in both ACI groups.However,lowering of NDS after treatment in the ACI treatment group were more apparent compare to those in the ACI control group(P﹤0.05).[Conclusion]Irbesartan can decrease serum level of leptin,and improve the recovery of neurological function in patients with ACI.
Key concepts: Irbesartan, Medicine, Leptin, Internal medicine, Blood lipids, Gastroenterology, Blood pressure, Endocrinology